Bakx Raises $25 Million To Develop Therapeutics Targeting Pro-Apoptotic Proteins And Mitochondrial Apoptosis Pathway
Amount Raised
$25 Million
Round Type
Funding Round
BearsvilleBiotechnologyMobilePrivacy And SecurityDescription
BAKX Therapeutics today announced it closed $25 million in a Series A fundraising led by AB Magnitude Ventures Group with Ipsen Pharma SA and Sherpa Healthcare Partners. The new funding will enable the company to drive its BAKX Activator Program into the clinic in hematologic malignancies and solid tumors and to advance additional targets for solid tumors and prevention of resistance. The financing comes on the heels of the company’s recent announcement of a partnership comprising up to $852 million in upfront and potential milestone payments with Ipsen, a global biopharmaceutical company, to research, develop, manufacture and commercialize the company’s lead candidate, BKX-001, as a potential treatment for leukemia, lymphoma and solid tumors.
Quick answer
Bakx Therapeutics raised $25 Million in a Funding Round round, dated November 18, 2021. Bakx Therapeutics is based in Bearsville, New York, United States.
- How much did Bakx Therapeutics raise?
- Bakx Therapeutics raised $25 Million in a Funding Round round on November 18, 2021.
- What does Bakx Therapeutics do?
- BAKX Therapeutics is a New York and Boston based company focused on developing safer, more effective therapeutics that fully realize the potential of the mitochondrial apoptosis pathways.
- Where is Bakx Therapeutics based and how big is it?
- Bakx Therapeutics is based in Bearsville, New York, United States.
Source: Fundz verified event record.
Who else raised in Mobile and Privacy And Security around the same time
Companies in the same sectors as Bakx Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Tasso raised $100M (Series B) on December 16, 2021.
- Device Authority raised $2.9M (Seed) on December 2, 2021.
- Notabene raised $10M (Funding Round) on November 8, 2021.
- DeepCure raised $40M (Series A) on November 8, 2021.
- Contraline raised $11M (Series A) on October 20, 2021.
- Immunoprofile raised $880K on December 31, 2021.
Who to call at Bakx Therapeutics, and when
A new round usually means Bakx Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bakx Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bakx Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bakx Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bakx Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Bakx Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.